Singapore markets open in 1 hour 20 minutes

SAB Biotherapeutics, Inc. (SABS)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
4.1000-0.1800 (-4.21%)
At close: 04:00PM EDT
4.1100 +0.01 (+0.24%)
After hours: 06:39PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2231
Avg. Estimate-0.96-1.03-3.04-6.21
Low estimate-0.98-1.14-4.9-6.21
High estimate-0.94-0.92-0.5-6.21
Year ago EPS-1.5-1.4-7.64-3.04
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2221
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago sales581k86k2.24MN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.8-1.45-1.17-0.62
Actual EPS-1.5-1.4-1-3.38
Difference-0.70.050.17-2.76
Surprise %-87.50%3.40%14.50%-445.20%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.96-1.03-3.04-6.21
7 days ago-0.96-1.03-3.04-6.21
30 days ago-0.46-0.46-1.94-1.94
60 days ago-0.46-0.46-1.94-1.94
90 days ago-0.46-0.46-1.94-1.94
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days111N/A
Growth estimatesSABSIndustrySector(s)S&P 500
Current qtr.36.00%N/AN/AN/A
Next qtr.26.40%N/AN/AN/A
Current year60.20%N/AN/AN/A
Next year-104.30%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A